Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China | |
Wei, Lai; Xie, Qing; Hou, Jin Lin; Jia, Jidong; Li, Wu; Xu, Min; Li, Jun; Wu, Shanming; Cheng, Jun; Jiang, Jianning | |
刊名 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
![]() |
2018 | |
卷号 | 33期号:6页码:1168-1176 |
关键词 | direct-acting antiviral agents NS5B polymerase inhibitor pangenotypic SVR12 |
DOI | 10.1111/jgh.14102 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4583638 |
专题 | 山东大学 |
作者单位 | 1.Peking Univ, Peoples Hosp, 11 Xizhimen S St, Beijing 100044, Peoples R China. 2.Capital Med Univ, Beijing Friendship Hosp, B |
推荐引用方式 GB/T 7714 | Wei, Lai,Xie, Qing,Hou, Jin Lin,et al. Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,2018,33(6):1168-1176. |
APA | Wei, Lai.,Xie, Qing.,Hou, Jin Lin.,Jia, Jidong.,Li, Wu.,...&Wang, Guiqian 更多.(2018).Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China.JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,33(6),1168-1176. |
MLA | Wei, Lai,et al."Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China".JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 33.6(2018):1168-1176. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论